Concepedia

Yoshiaki Katsuda

YK

Statistics

Publications

17

Citations

884

H-Index

16

Active since

1993

Affiliations

Japan Tobacco (Japan)(Current)

Japan Tobacco (United States)

Orphagen Pharmaceuticals (United States)

Niigata University

University of Oxford

Yoshiaki Katsuda is an author at Japan Tobacco (Japan) specializing in medicine, pharmacology, and diabetes mellitus.

Publications per year

1993–2023

17

Publications

17

A New Spontaneously Diabetic Non‐obese Torii Rat Strain With Severe Ocular Complications

Masami Shinohara, Taku Masuyama, Toshiyuki Shoda et al. · Journal of Diabetes Research · 1999 · 178 citations · Full text

Medicine, Endocrinology, Physiology +10

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A Novel Model of Obesity-Related Diabetes: Introgression of the Leprfa Allele of the Zucker Fatty Rat into Nonobese Spontaneously Diabetic Torii (SDT) Rats

Taku Masuyama, Yoshiaki Katsuda, Masami Shinohara · EXPERIMENTAL ANIMALS · 2005 · 87 citations · Full text

Medicine, Endocrinology, Genetics +16

A novel<scp>JAK</scp>inhibitor<scp>JTE</scp>‐052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents

Atsuo Tanimoto, Yuichi Shinozaki, Yasuo Yamamoto et al. · Experimental Dermatology · 2017 · 60 citations · Full text

Medicine, Dermatology, Pharmacology +17

1–5 of 17